TY  - JOUR
AU  - Müller, Patrick
AU  - Vellage, Anne-Katrin
AU  - Schmicker, Marlen
AU  - Menze, Inga
AU  - Grothe, Michel J
AU  - Teipel, Stefan J
AU  - Müller, Notger G
PY  - 2021
DO  - 10.1002/trc2.12153
UR  - https://hdl.handle.net/10668/27389
T2  - Alzheimer's & dementia (New York, N. Y.)
AB  - Cholinesterase inhibitors can enhance cognitive functions in healthy elderly and delay cognitive decline in patients with Alzheimer`s disease (AD). However, not everyone benefits from this treatment (non-responders). Current studies show clinical...
LA  - en
PB  - John Wiley & Sons, Inc.
KW  - Alzheimer's disease
KW  - basal forebrain
KW  - galantamine
KW  - magnetic resonance imaging
KW  - personalized medicine
KW  - Humans
KW  - Aged
KW  - Galantamine
KW  - Cholinesterase Inhibitors
KW  - Basal Forebrain
KW  - Alzheimer Disease
KW  - Cognitive Dysfunction
TI  - Structural MRI of the basal forebrain as predictor of cognitive response to galantamine in healthy older adults-A randomized controlled double-blinded crossover study.
TY  - research article
VL  - 7
ER  -